Kim DI et al. 37 have shown that LXRα and protein arginine N-methyltransferase 3 (PRMT3) expressions are increased in cellular and mouse models of NAFLD and in humans. This evidence concerns the gene PRMT3 and metabolic dysfunction-associated steatotic liver disease.